Skip to main content
. 2013 Mar 25;19(1):51–59. doi: 10.3350/cmh.2013.19.1.51

Table 5.

Clinical features of six patients with HBV reactivation secondary to rituximab therapy

graphic file with name cmh-19-51-i005.jpg

*Baseline test.

Pt., patient; M, male; F, female; ALT, alanine aminotransferase; TB, total bilirubin; NA, not available; LMV, lamivudine; ETV, entacavir; ADV, adefovir; LT, liver transplantation.